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Introduction: Robotic systems are designed to address the limitations of laparoscopic surgery, leading to
a growing interest in robotic rectal surgery. However, certain technical limitations associated with the
previous systems (da Vinci S & Si) have arguably slowed down its wholesale adoption. The latest robotic
platform, the da Vinci Xi, addresses these limitations. This study aims to examine the short-term surgical
outcomes of 240 single-docking fully-robotic rectal cancer resections and compare the outcomes of cases
performed with the da Vinci Xi vs Si systems.
Materials and methods: All consecutive patients receiving robotic rectal cancer resections from three
centres between 2013 and 2018 were identiﬁed from prospectively collated databases. The baseline
characteristics and short-term surgical outcomes are presented and the da Vinci Xi vs Si system out-
comes are analysed.
Results: A total of 240 patients were identiﬁed (124 Si, 116 Xi). Median operation-time and length-of-stay
were 260 minutes and 6 days respectively. Conversion and 30-day mortality rates were 0. The da Vinci Si
vs Xi system analysis shows that operation-time was lower in the Si group (230 vs 300 min, p ¼ 0.000)
but length-of-stay, lymph node yield and circumferential resection margin favoured the Xi group (7 vs 5
days, p ¼ 0.010; 17 vs 21, p ¼ 0.000; 92.7% vs 99.1%, p ¼ 0.020).
Conclusion: Single-docking fully-robotic rectal cancer surgery is safe, feasible and can lead to good short-
term outcomes, making it a good alternative to laparoscopic rectal cancer surgery. The new systems
technological advances may result in better short-term outcomes but further larger scale observational
studies are required if we are to reach such a conclusion.
© 2019 Sir Run Run Shaw Hospital afﬁliated to Zhejiang University School of Medicine. Published by
Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Despite the increasing adoption of laparoscopic colonic surgery
over the last 15 years, laparoscopic rectal surgery uptake has been
poor and concerns regarding specimen quality have been high-
lighted in the ACOSOG Z6051 and ALaCaRT trials.1,2 Robotic systems
offer a contemporary method of operating, which with their su-
periorly ergonomic, wristed instruments, tremor ﬁltering and
three-dimensional views address the limitations of laparoscopic
surgery when operating in conﬁned spaces such as the pelvis.3 The, School of Health and Care
United Kingdom.
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2.002growing interest in robotic rectal surgery over the last few years is
evident from the increasing number of research publications on the
subject.4,5 However, the worldwide adoption of robotic systems has
been arguably slowed down by certain technical limitations asso-
ciated with the previous models (da Vinci S & Si).6 These included
prolonged docking times, arm clashing and difﬁculties in per-
forming multi-quadrant surgery.7 After taking into consideration
feedback given from surgeons from different surgical specialities,
Intuitive Surgical® introduced the da Vinci Xi® in 2014. This model
included several technological advances designed to overcome the
limitations of its predecessors. However, whether this improved
version offers superior short-term surgical outcomes is
understudied.Medicine. Published by Elsevier B.V. This is an open access article under the CC BY-
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performing robotic rectal surgery since May 2013, starting with the
da Vinci Si and then with the da Vinci Xi and integrated table
motion (ITM) since November 2015. The senior surgeon (Amjad
Parvaiz) performing the robotic cases in Portsmouth, supervised
the adoption of robotic rectal surgery at the units in Poole and
Lisbon. We describe our experience of robotic rectal cancer surgery
with the two systems over the last 5 years by analysing the short-
term outcomes of 240 consecutive cases. In addition, we compare
the short-term surgical outcomes of the da Vinci Xi rectal cancer
resections with the resections performed with the da Vinci Si in
order to investigate whether the technological advances offered by
the Xi system are translated to superior surgical outcomes. To date,
and as far as we are aware, this study represents the largest robotic
rectal surgery series in Europe and the largest study comparing the
outcomes of the patients receiving robotic rectal cancer surgery
with the two platforms.2. Materials and methods
2.1. Study population and participant selection
Consecutive cases from three centres, two from the UK (Ports-
mouth, Poole) and one from Portugal (Lisbon), who received ro-
botic rectal cancer resection surgery between May 2013 and May
2018 were identiﬁed from prospectively maintained databases. The
inclusion criteriawere all elective patients deemed ﬁt forminimally
invasive surgery receiving robotic rectal surgery for adenocarci-
noma of the rectum. Benign cases and colonic cancer patients were
excluded. The primary objective of this study was to analyse the
collective short-term outcomes of all robotic rectal cancer cases.
This was in order to examine the feasibility and safety of robotic
rectal surgery. The secondary objective was to examine the short-
term outcomes of resections performed with the da Vinci Xi vs da
Vinci Si systems.
All cancer patients involved in this study were discussed in the
multidisciplinary team meeting prior to initiating any type of
treatment. In general, preoperative chemoradiotherapy was given to
patients with high risk for local recurrence (threatened circumfer-
ential resection margin  2mm or T4 in staging MRI). Neoadjuvant
radiotherapy was not used where rectal cancers were considered
resectable by total mesorectal excision (TME) with a good likelihood
of clear margins. Patients receiving neoadjuvant chemoradiotherapy
were operated at 12 weeks after completion of their treatment. A
modiﬁed enhanced recovery programmewas used as standard at all
colorectal units in this study.8
All patients operated in the ﬁrst unit (Portsmouth) received
surgery with the da Vinci Si. Patients operated in the remaining two
units (Poole and Lisbon) received surgery with the da Vinci Xi and
ITM. No speciﬁc criteria were used to allocate patients to robotic
surgery in each unit. Applied surgical modality was based on
equipment and theatre availability, with the robotic approach being
preferred following the adoption of robotic surgery in each unit.
There were no speciﬁc medical contra-indications for robotic sur-
gery that did not apply for laparoscopic surgery and any patients
who were deemed unﬁt or unsuitable to undergo laparoscopic
surgery were excluded from consideration for robotic surgery.
These included patients requiring multi-visceral resections, pa-
tients with large incisional hernias requiring abdominal wall
reconstruction after resection and those who could not tolerate
pneumoperitoneum.
Patients included in the study had surgery performed by four
colorectal surgeons. The surgeon from one of the centres (surgeonPlease cite this article as: Panteleimonitis S et al., Robotic rectal cance
resections and comparative analysis between cases performed with the
Surgery, https://doi.org/10.1016/j.lers.2019.12.002AP) represented the senior surgeon who trained the remaining
three surgeons under a supervised training programme. As a result,
all surgeons used the same standardised modular approach. Data
collection is from the acquisition of the robotic system in each unit
(May 2013, November 2015 and May 2016 for Portsmouth, Poole
and Lisbon respectively) to February 2016 for Portsmouth and May
2018 for Poole and Lisbon units.2.2. Surgical technique
Robotic rectal resections were performed using previously
described standardised single-docking fully-robotic approaches for
both systems.6,9 This was possible for the da Vinci Si system by
changing the port conﬁguration and ﬂipping the robotic arms be-
tween the stages of abdominal and pelvic dissection,9 a step not
required with the Xi system.6 Procedures commenced with medial
to lateral dissection followed by vascular control by ligating the
main vessels, followed by a three-step approach for splenic ﬂexure
mobilisation.10 TME was performed in a stepwise manner, starting
with posterior mobilisation followed by right lateral, anterior and
left lateral mobilisation. All patients receiving complete TME sur-
gery (i.e. for mid- and low-rectal tumours) were given pre-
operative bowel preparation the day before surgery and had loop
ileostomies fashioned where an anastomosis was formed. Post-
operatively, all patients were managed using the enhanced recov-
ery program described by Kehlet and Wilmore.8 Patients were
discharged home only upon safely meeting the criteria for
discharge.2.3. Data collection and outcome assessment
All data was collected from prospectively maintained databases,
with the baseline characteristics and short-term surgical outcomes
of all elective patients receiving robotic rectal cancer surgery being
retrospectively collected and analysed. Baseline characteristics
analysed included age, body mass index (BMI), gender, American
Society of Anaesthesiologist (ASA) grade, neoadjuvant radio-
therapy, operation performed and pathological T stage. Peri-
operative data included operative time, estimated blood loss
(EBL) and conversion to open (deﬁned as any incision needed to
either mobilise the colon or rectum or ligate the vessels). Post-
operative clinical data examined included length of stay (LOS),
30-day readmission, 30-day reoperation, 30-day mortality and
clinical anastomotic leak (deﬁned as an anastomotic leak requiring
re-intervention such as a drain or further surgery). It should be
noted that all patients requiring TME had defunctioning loop
ileostomies, and therefore a low number of clinical anastomotic
leaks is expected. Pathological data examined included lymph node
yield and circumferential resection margin (CRM) clearance. Un-
fortunately, operative time was not recorded in the Portuguese
centre.2.4. Statistical analysis
Datawas analysed using IBM SPSS version 24 (SPSS Inc., Chicago,
IL, USA). Non-parametric data was expressed as median with
interquartile range (IQR) and parametric data as mean with stan-
dard deviation. Baseline demographic and clinical characteristics
were compared using c2 test or Fishers exact test for categorical
variables, ManneWhitney U test for non-parametric continuous
variables and t test for parametric continuous variables. p values of
<0.05 were considered statistically signiﬁcant.r surgery: Results from a European multicentre case series of 240
da Vinci Si and Xi systems, Laparoscopic, Endoscopic and Robotic
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all patients receiving elective robotic rectal cancer surgery to assess
whether robotic platform (da Vinci Si or Xi) affected CRM clearance.
Following this, a multivariate model was applied were platform
used was adjusted for all clinically relevant variables (age, gender,
BMI, ASA grade, pathological T stage, neoadjuvant radiotherapy).
For the purpose of binary logistic regression missing values were
replaced with the series mean (10 for ASA, 3 for T stage, 12 for BMI).2.5. Ethical considerations
All included patients signed an informed consent allowing their
data to be used for retrospective analysis and research. The re-
quirements for anonymization of personal dataset by the Data
Protection Act 1998 were satisﬁed. According to the Health
Research Authority, this study did not require their approval due to
its status as a clinical audit.3. Results
3.1. Total cohort
A total of 240 patients received robotic rectal cancer surgery
(124 Si, 116 Xi). Baseline characteristics and short-term surgical
outcomes are summarised in Tables 1 and 2. The majority of the
cases were male (66.7%), ASA grade II (77.0%) and received anterior
resections (86.7%). Sixty-six (27.5%) patients received neoadjuvant
radiotherapy. Median operative time was 260 minutes and median
LOS was 6 days. There were no conversions to open, or 30-day
mortality. Four clinical anastomotic leaks were documented and
R0 clearance rate was 95.8%.Table 1
Baseline characteristics of robotic rectal cancer resections
Robotic rectal cancer
resections (n ¼ 240)
Median age (IQR), years old 69 (60e75)
Median BMI (IQR), kg/m2 27 (24e30)
System, n(%)
Si 124 (51.7)
Xi 116 (48.3)
Centre, n(%)
Portsmouth (Si) 124 (51.7)
Poole (Xi) 80 (33.3)
Lisbon (Xi) 36 (15.0)
Gender, n(%)
Male 160 (66.7)
Female 80 (33.3)
ASA grade, n(%)
I 17 (7.4)
II 177 (77.0)
III 35 (15.2)
IV 1 (0.4)
Procedure, n(%)
Anterior resection 208 (86.7)
APER 29 (12.1)
Hartman's 2 (0.8)
Panproctocolectomy 1 (0.4)
Neoadjuvant radiotherapy, n(%) 66 (27.5)
Pathological T stage, n(%)
0 12 (5.1)
1 29 (12.2)
2 77 (32.5)
3 104 (43.9)
4 15 (6.3)
ASA: American Society of Anaesthesiologist; APER: Abdominoperineal resection.
Please cite this article as: Panteleimonitis S et al., Robotic rectal cance
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3.2.1. Baseline characteristics
There was a total of 124 and 116 rectal resections performed
with the da Vinci Si and Xi systems respectively.
There were no signiﬁcant differences in any of the baseline
characteristics between the two cohorts as demonstrated in
Table 3.
3.2.2. Peri-operative outcomes
The peri-operative outcomes of the two groups are summarised
in Table 4. Median operation time was greater in the da Vinci Xi
group (230 vs 300min, p¼ 0.000). EBL was higher in the da Vinci Xi
group (10 vs 20 ml, p ¼ 0.000). There were no conversions to open
in either cohort.
3.2.3. Post-operative outcomes
LOS was shorter in the da Vinci Xi group (7 vs 5 days, p ¼ 0.010).
There was no difference in any of the remaining clinical outcomes
between the two groups (30-day readmission, reoperation, mor-
tality and anastomotic leak). In terms of pathological outcomes,
lymph node yield (17 vs 21, p ¼ 0.000) and R0 clearance rate (92.7%
vs 99.1%, p ¼ 0.024) were higher in the Xi cohort. Table 5 sum-
marises the post-operative outcomes.
3.2.4. Logistic regression analysis for CRM clearance
Univariate logistic regression analysis infers that robotic plat-
forms have an impact on CRM, with the Xi system associated with a
lower risk of achieving a R1 resection (OR: 0.111 [95% CI:
0.014e0.891], p ¼ 0.039). This was still the case in multivariate
analysis (OR: 0.092 [95% CI: 0.011e0.764], p ¼ 0.027) when other
clinically relevant factors were adjusted for (age, gender, BMI,
neoadjuvant radiotherapy, ASA grade, pathological T stage), as
demonstrated in Table 6.
4. Discussion
Laparoscopy has revolutionised colonic surgery but its adoption
has been much less successful for rectal cancer surgery. This could
be attributed to the inherent limitations of laparoscopic in-
struments when operating in narrow spaces such as the pelvis,
which were highlighted in two large multi-centre randomised
control trials (ACOSOG Z6051 & ALaCaRT) comparing laparoscopic
to open rectal resections.1,2 In both studies the oncological equiv-
alence of laparoscopic to open rectal surgery is debated, raising
suspicion of the safety of laparoscopic rectal surgery. Robotic sys-
tems were designed to address these limitations and may provide
the solution to minimally invasive surgery for rectal cancer
resections.
In this study we present the data of 240 robotic rectal cancer
cases over a period of 5 years. By applying a standardised, modular
approach to surgery, fully-robotic single-docking robotic surgery
was performed with good short-term surgical outcomes. The
absence of any conversions (conversion ratewas 11.3% and 9% in the
ACOSOG Z6051 & ALaCaRT trials respectively) and relatively low
number of clinical anastomotic leaks, 30-day readmissions and
reoperations is testimony to the successful implementation of the
robotic rectal surgery programme in the three units participating in
this study.1,2 In addition, the R0 resection ratewas 95.8%, in contrast
to 87.9% and 93% in the ACOSOG Z6051& ALaCaRT trials.1,2 This data
shows that robotic rectal surgery is safe and could be used as an
alternative to laparoscopic rectal surgery in similar sample
populations.
To date there have been multiple studies comparing the short-
term outcomes of laparoscopic vs robotic rectal surgery withr surgery: Results from a European multicentre case series of 240
da Vinci Si and Xi systems, Laparoscopic, Endoscopic and Robotic
Table 2
Short-term outcomes of robotic rectal cancer resections
Robotic rectal cancer resections (n ¼ 240)
Median operative time in minutes (IQR) 260 (210e310)
Median estimated blood loss in ml (IQR) 20 (10e20)
Conversion to open, n 0
Median length of stay in days (IQR) 6 (4e8)
30-day readmission, n(%) 19 (7.9)
30-day reoperation, n(%) 12 (5.0)
30-day mortality, n(%) 0
Clinical anastomotic leak, n(%) 4 (1.9)
Median lymph node yield in number (IQR) 19 (14e25)
R0 clearance, n(%) 230 (95.8)
Table 3
Baseline characteristics of da Vinci Si vs Xi system cases
Si (n ¼ 124) Xi (n ¼ 116) p value
Median age (IQR), years old 68 (62e76) 69 (60e77) 0.115m
Median BMI (IQR), kg/m2 27 (24e30) 28 (24e31) 0.221m
Gender, n(%)
Male 86 (69.4) 74 (63.8) 0.361c
Female 38 (30.6) 42 (36.2)
ASA grade, n(%)
I 10 (8.5) 7 (6.3) 0.467c
II 93 (78.8) 84 (75.0)
III 15 (12.7) 20 (17.9)
IV 0 1 (0.9)
Procedure, n(%)
Anterior resection 109 (87.9) 99 (85.3) 0.253c
APER 12 (9.7) 17 (14.7)
Hartman's 2 (1.6) 0
Panproctocolectomy 1 (0.8) 0
Neoadjuvant radiotherapy, n(%) 30 (24.2) 36 (31.0) 0.236c
Pathological T stage, n(%)
0 5 (4.0) 7 (6.2) 0.246c
1 18 (14.5) 11 (9.7)
2 45 (36.3) 32 (28.3)
3 51 (41.1) 53 (46.9)
4 5 (4.0) 10 (8.8)
ASA: American Society of Anaesthesiologist; APER: Abdominoperineal resection.
m ManneWhitney U.
c Chi square.
Table 4
Peri-operative outcomes of da Vinci Si vs Xi system cases
Si (n ¼ 124)
Median operative time in minutes (IQR) 230 (204e300)
Median estimated blood loss in ml (IQR) 10 (0e20)
Conversion to open, n 0
m ManneWhitney U.
b Statistically signiﬁcant.
Table 5
Post-operative clinical and pathological outcomes of da Vinci Si vs Xi system cases
Si (n ¼ 124
Median length of stay in days (IQR) 7 (5e12)
30-day readmission, n(%) 10 (8.1)
30-day reoperation, n(%) 4 (3.2)
30-day mortality, n(%) 0
Anastomotic leak, n(%) 4 (3.6)
Median lymph node yield in number (IQR) 17 (13e23)
R0 clearance, n(%) 115 (92.7)
m ManneWhitney U.
c Chi-square.
f Fishers exact test.
d Statistically signiﬁcant.
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Surgery, https://doi.org/10.1016/j.lers.2019.12.002contradictory results.5,11e19 The majority of the evidence consists of
small scale retrospective comparative studies but more recently the
results of the ROLARR trial were published, a multi-centre rando-
mised control trial comparing robotic and laparoscopic rectal re-
sections which found no difference in the short-term outcomes of
the two arms.20 However, this trial was performed when robotic
rectal surgery was in its infancy and the da Vinci Xi was unlikely to
be used in any of the trial's centres considering recruitment ended
in September 2014. In the ROLARR trial conversion rate was 12.2%
for the laparoscopic and 8.1% for the robotic cohorts (p ¼ 0.16),
which is considerably higher than the conversion rate observed in
our study and may be explained in part by the fact that many of the
surgeons were still in the early stages of their learning curve for
robotic rectal surgery.21
Despite the increasing adoption of robotic rectal cancer surgery,
the da Vinci Si system presented several technical limitations that
were recognised by surgeons performing robotic rectal resections.
These mainly entailed a difﬁcult and complex docking process,
repeated arm clashing and difﬁculties in performing multi-
quadrant surgery. The issue of multi-quadrant surgery with the
da Vinci Si has been addressed by colorectal surgeons with a variety
of methods, leading to multiple robotic rectal resection techniques,
such as the hybrid-approach and dual docking approach. In our
centre in Portsmouth we managed to perform single docking fully
robotic surgery with the da Vinci Si, but this required changing the
port conﬁguration and ﬂipping the robotic arms between the stagesXi (n ¼ 116) p value
300 (240e330) 0.000m,b
20 (20e20) 0.000m,b
0
) Xi (n ¼ 116) p value
5 (3e8) 0.010m,d
9 (7.8) 0.930c
8 (6.9) 0.242f
0
0 0.123f
21 (16e27) 0.000m,d
115 (99.1) 0.024f,d
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Table 6
Univariate and multivariate logistic regression for CRM of robotic rectal cancer resections (n ¼ 240)
OR Univariate OR Multivariate
95% CI lower 95% CI upper p value 95% CI lower 95% CI upper p value
Platform (Xi vs Si) 0.111 0.014 0.891 0.039a 0.092 0.011 0.764 0.027a
Age 1.030 0.966 1.099 0.362 1.020 0.944 1.102 0.613
Gender (male vs female) 0.484 0.136 1.723 0.263 0.436 0.116 1.636 0.219
BMI 0.952 0.809 1.121 0.556 0.947 0.792 1.132 0.550
Neoadjuvant radiotherapy 1.806 0.493 6.617 0.372 2.056 0.525 8.048 0.301
ASA grade (I-II vs III) 0.694 0.141 3.408 0.653 0.719 0.118 4.373 0.720
Pathological T stage (T0-2 vs T3-4) 0.407 0.103 1.612 0.200 0.339 0.081 1.423 0.140
OR: odds ratio; CI: conﬁdence interval; ASA: American Society of Anaesthesiologist.
OR represents the odds ratio of performing an R1 resection.
a Statistically signiﬁcant.
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signed patient cart with new overhead instrument arm architec-
ture, coupled with a laser target system making docking much
easier, quicker and enabling multi-quadrant surgery without hav-
ing to reposition the patient cart or change the port conﬁguration.
Furthermore, the da Vinci Xi comes with thinner longer arms
equipped with newly designed joints that offer a greater range of
freedom of motion, therefore reducing arm clashing. The ITM al-
lows for the table to be moved while the patient cart is docked,
facilitating robust splenic ﬂexure mobilisation since the patient can
be moved from the head down to the head up position without
undocking the robot, displacing the transverse colon downwards
and therefore assisting in separating the omentum from the
transverse colon.
Another major contribution has been the introduction of the
robotic stapler for intracorporal division of the rectal tube following
resection. The versatile design of this equipment with fully wristed
manipulations performed from the surgeon console greatly facili-
tates low rectal tube division and improves sphincter preservation
rates. These technological advances have made the da Vinci Xi an
even more attractive tool for robotic rectal surgery, facilitating ro-
botic splenic ﬂexure mobilisation and the single-docking fully-ro-
botic approach. This has led to two studies comparing the da Vinci
Si and Xi systems by assessing the number of splenic ﬂexure
mobilisations and fully-robotic single-docking approaches per-
formed with each system.7,22 Both studies concluded that there
were more splenic ﬂexure mobilisations performed in the da Vinci
Xi cohort's and Morelli et al also reported a higher number of fully-
robotic procedures (100% vs 23%) for the Xi system.7
However, using splenic ﬂexure mobilisations and fully-robotic
procedures as reported outcomes and markers of success present
a signiﬁcant limitation, since procedures may have been performed
with the hybrid-approach or splenic ﬂexures not mobilised for
reasons other than the platform deployed, such as training pur-
poses, clinical need or surgeon choice. In our cohort we routinely
used the fully-robotic approach for all cases and splenic ﬂexure
mobilisation was completed routinely in all resections requiring a
colorectal or coloanal anastomosis.
In comparing the short-term surgical outcomes of the da Vinci Si
and Xi we found that operative time and EBL was higher for the Xi
group (see Table 4) but LOS, lymph node yield and CRM favoured
the Xi group (see Table 5). The increased operative time is in direct
contrast to what we would expect when considering the techno-
logical advances of the Xi system and available literature.7,23 This
could be attributed to the fact that the Xi cases include twenty
training cases with the remaining (n ¼ 60) performed by surgeons
in the early stages of their robotic surgery experience.
When considering EBL, our results show that the observed dif-
ference between the two systems is of no clinical signiﬁcance (10 vsPlease cite this article as: Panteleimonitis S et al., Robotic rectal cance
resections and comparative analysis between cases performed with the
Surgery, https://doi.org/10.1016/j.lers.2019.12.00220 ml) and is more likely to be attributed to the way EBL was
measured in each unit rather than any real difference. However, it is
worth noting is that EBL was minimal in both systems, which is in
agreement with other published reports that demonstrate an
improved blood loss in robotic vs laparoscopic rectal cancer
surgery.5,24,25
Median LOS was shorter in the da Vinci Xi cohort with results
inferring that a reduction in LOS could be attributed to a reduction
in post-operativemorbidity. This is supported by two recent studies
published by the Cleveland clinic group who reported that LOS,
readmission rate and mortality effectively predict complica-
tions.26,27 However, differences in the enhanced recovery protocols
between the units of this study are likely to inﬂuence the observed
differences in LOS. The da Vinci Si cases took place in an earlier
chronological time scale, were epidural catheters were applied
more routinely as part of the enhanced recovery protocol. Subse-
quently, our results would now favour a single shot spinal inﬁl-
tration of marcaine and diamorphine prior to anaesthesia for
analgesia and avoid epidural catheters, which could lead to earlier
mobilisation of patients and therefore a speedier recovery. Exam-
ining the relevant published literature, from the three studies
comparing the surgical outcomes of da Vinci Si and Xi rectal re-
sections,7,22,23 one study demonstrated a shorter LOS in the Si
group (5.1 vs 6.2 days; p ¼ 0.001),23 one study reported a shorter
LOS in the Xi group (although this did not reach statistical signiﬁ-
cance: 8.0 vs 6.5 days; p ¼ 0.077),7 and one study found no dif-
ference at all (5.7 vs 6.0 days).22
Lymph node yield and R0 clearance were higher in the da Vinci
Xi group (see Table 5). A higher lymph node yield was also found in
the Xi group in the study reported by Ozben et al,23 although this
was not the case in multivariate analysis. Anastomotic leak, 30-day
readmission, reoperation andmortality rates did not differ between
the two groups. Differences in R0 clearance, which are conﬁrmed in
univariate and multivariate regression analysis in our study popu-
lation, could be partly due to the slimmer arm design of the console.
This reduces arm clashing, which can potentially hinder the precise
dissection of the mesorectum when operating in the deep pelvis.
The advances in the da Vinci Xi system have undoubtedly made
single-docking fully-robotic rectal surgery more attainable and are
likely to obliterate the need for hybrid- or dual-docking procedures.
In our experience colorectal surgeons report ﬁnding the da Vinci Xi
system to be a more forgiving, user-friendly console that is easier to
learn when compared to the Si system. However, whether this
translates to improved short-term outcomes is yet to be
established.
Limitations of this study include the retrospective nature of the
study and the fact that minor post-operative complications were
not recorded (Clavien-Dindo 1e2). This is because minor compli-
cation data is harder to accurately record and can be easily missed.r surgery: Results from a European multicentre case series of 240
da Vinci Si and Xi systems, Laparoscopic, Endoscopic and Robotic
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Vinci Si system had a signiﬁcantly larger minimally invasive colo-
rectal surgery experience which could skew the results reported.
Moreover, the chronological order differences in data collection
between the two groups (May 2013 to February 2016 for the da
Vinci Si system vs November 2015 to May 2018 for the Xi system)
present signiﬁcant observational bias in this study and differences
in outcomes could be confounded by advances in peri-operative
management. Finally, the fact that there was only one kind of ro-
botic system present in each participating centre presents further
observation bias. This is because differences in outcomes could be
attributed to differences in the care provided between the study's
participating centres, rather than in the robotic systems
themselves.
The main strengths include that data was collected form three
centres from two countries and is contemporary data, rather than
data collected as part of a trial that inevitably includes an element
of performance bias in surgical trials.28,29 Further strengths are that
this study, as far as is known, is the largest of its kind and includes
the largest European case series of single-docking fully-robotic
rectal cancer resections.
5. Conclusions
In conclusion, single-docking fully-robotic rectal cancer surgery
is safe and effective and can lead to good short-term surgical out-
comes, making it a good alternative option to laparoscopic rectal
cancer surgery. The new system's technological advances facilitate
better intraoperative control of operative ﬁelds, which in turn may
result in better short-term outcomes, but further larger scale
observational studies are required if we are to reach such a
conclusion.
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